Firsthand observations from
Prof. Jochen Whörle
Hear the impact of cerebral embolic protection described as observed in the largest propensity matched meta-analysis comparison of All-Stroke and mortality.
Seeing is believing
In 99% of procedures, SENTINEL was shown to capture and remove stroke-causing embolic debris.1
A growing body of evidence
SENTINEL leads the way in clinical evidence for cerebral embolic protection for over 2,600 patients across a randomized trial and multiple registries.
1. SENTINEL IDE Trial. Data presented at SENTINEL FDA Advisory Panel, Feb 23, 2017.; 2. Van Mieghem N., TVT 2018 (includes TIA); 3. Stripe, B. PCR LV 2019; 4. Rinaldi, TCT 2018. 5. Chakravarty T., TCT 2018; 6. Seeger J., et al., JACC Cardiovasc Interv. 2017.
Fisher exact test; Results from different studies are not directly comparable. Information provided for educational purposes only.